Nurse Practitioner · Manhattan, KS
NPI
1962630871
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1133 College Ave, G100
Manhattan, KS, 66502
Phone (785) 537-8710
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,984 services
Medicare patients, 2024
456
Average age 76
Drug cost, 2024
$288K
1,465 prescriptions
Company payments, 2025
$643
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy D Meusborn was code 99214 (office e&m - established), 403 times for 265 patients. In total Amy D Meusborn billed 1,984 services in 41 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 403 | 265 | $77.46 | $31K |
| 99213 Office E&M - Established | Office | 142 | 115 | $53.70 | $7,625 |
| 81001 Clinical Chemistry | Office | 117 | 92 | $3.11 | $364 |
| 95972 Electrical Nerve Conductivity | Office | 108 | 55 | $34.87 | $3,766 |
| 81003 Clinical Chemistry | Office | 103 | 94 | $2.15 | $221 |
| 51792 Electrical Nerve Conductivity | Office | 86 | 86 | $153.78 | $13K |
| 51798 Ultrasound - Nonspecific | Office | 64 | 57 | $7.72 | $494 |
| 99204 Office E&M - New | Office | 45 | 45 | $101.60 | $4,572 |
| 99214 Office E&M - Established | Facility | 38 | 26 | $55.59 | $2,112 |
| 51741 Test - Miscellaneous | Office | 24 | 24 | $5.19 | $125 |
| 51728 Other Organ Systems | Office | 20 | 20 | $222.65 | $4,453 |
| 51797 Other Organ Systems | Office | 18 | 18 | $121.11 | $2,180 |
| 99211 Office E&M - Established | Office | 17 | 16 | $15.15 | $257 |
| 99213 Office E&M - Established | Facility | 14 | 13 | $34.20 | $479 |
| 51701 Other Organ Systems | Office | 14 | 13 | $28.94 | $405 |
By year: 2022 $65K for 18,004 services; 2023 $82K for 9,552 services; 2024 $81K for 1,984 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 117 | 92 | $3.11 | $364 |
| 81003 Clinical Chemistry | 103 | 94 | $2.15 | $221 |
Medicare prescription drug claims, 2024
In 2024, the drug Amy D Meusborn prescribed most often to Medicare patients was Gemtesa (Vibegron), with 278 prescriptions and refills. In total Amy D Meusborn wrote 1,465 Medicare prescriptions that cost $288K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 278 | 341 | 51 | $153K |
| Myrbetriq Mirabegron | 187 | 244 | 29 | $92K |
| Solifenacin Succinate Generic | 151 | 206 | 40 | $5,637 |
| Methenamine Hippurate Generic | 138 | 160 | 23 | $5,924 |
| Estradiol Generic | 83 | 347 | 66 | $5,593 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 74 | 74 | 54 | $814 |
| Trospium Chloride Generic | 71 | 77 | 13 | $2,204 |
| Cefaclor Generic | 49 | 49 | 21 | $2,141 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 39 | 39 | 20 | $521 |
| Tamsulosin Hcl Generic | 34 | 76 | Under 11 | $492 |
| Cefuroxime Cefuroxime Axetil | 33 | 33 | 17 | $379 |
| Levofloxacin Generic | 32 | 32 | 25 | $122 |
| Fluconazole Generic | 31 | 31 | 25 | $98.5 |
| Finasteride Generic | 28 | 42 | Under 11 | $274 |
| Nortriptyline Hcl Generic | 24 | 30 | Under 11 | $124 |
Brand drugs: 492 claims; generic drugs: 973 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy D Meusborn $643 ($643 in general payments such as food, travel and fees) from 11 companies. The largest payer was Janssen Biotech, Inc. with $178.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $178 |
| Abbvie Inc. ABBV | 11 | $136 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $99.19 |
| Pfizer Inc. PFE | 3 | $73.31 |
| 180 Medical, Inc. | 2 | $51.6 |
| Urogen Pharma, Inc. URGN | 1 | $22.96 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $18.94 |
| Teleflex LLC TFX | 1 | $18.64 |
| Boston Scientific Corporation BSX | 1 | $15.12 |
| Tolmar, Inc. | 1 | $14.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.